Moreover, CD4 CTL and GZMK+ CD4 CTL from patients with IgG4-RD were more likely to respond to IFN-γ and IL-1 (Figure 6D). This evidence concerns the gene GZMK and immunoglobulin G4-related sclerosing disease.